oral formulation

ship flagship sail ocean boats
Biotech

Viking to charge quickly into phase 3 with obesity med

Viking will launch a longship into phase 3 for the obesity drug VK2735 sooner than expected, with a clinical program expected to top $300 million.
Annalee Armstrong Jul 25, 2024 9:19am
Photo of a construction worker sealing a layer of brick

Structure patches up shares after GLP-1 linked to 6% weight loss

Jun 3, 2024 10:17am
pushing rock up hill battle double hard difficult

Pfizer drops oral obesity drug after seeing liver safety concern

Jun 26, 2023 9:11am
pretty pills medication drugs pill tablet

Lilly links oral drug to 15% weight loss, setting bar for Pfizer

Jun 26, 2023 8:35am
cough

Merck's chronic cough med gets a nay from FDA

Jan 24, 2022 10:50am
hearing ear

Sensorion sinks as lead hearing loss med fails phase 2

Jan 19, 2022 10:03am